fbpx
Health

Reuters exclusively reports Pfizer’s COVID-19 vaccine supply to the EU 30% below plans

Reuters exclusively reported that Pfizer has not yet delivered to the European Union about 10 million COVID-19 vaccine doses that were due in December, leaving it about one-third short of the supplies it had expected by now from the U.S. company. The delay is another blow to the EU, which has also been hit by delays in deliveries from Anglo-Swedish drugmaker AstraZeneca and U.S. company Moderna, and had also faced earlier delays on the Pfizer vaccine. It also raises questions about the rationale of an EU vaccine export control scheme which was set up in late January to ensure timely deliveries but has not yet been activated, despite the supply shortfalls.

Article Tags
Topics of Interest: Health
Type: Reuters Best
Sectors: Pharmaceuticals & Healthcare
Regions: Europe
Countries: Belgium
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text
Customer Impact: Major Global Story
Sign up for email updates

Subscribe
Sign up for email updates